Marex Group Limited (MRX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 25, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MRX SEC filings page.
Marex Group Limited (MRX) reported $2.0B in revenue for fiscal year 2025, up 26.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Marex earns rising profits on a liability-funded balance sheet, while cash generation fluctuates more than reported income.
Net margin expanded to15.2% in FY2025, while FCF margin fell to32.3% . That earnings-to-cash divergence means stronger reported earnings did not translate into proportionally stronger cash generation, despite assets reaching$34.7B .
FY2025 assets were
Net income rose
Financial Health Signals
Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Marex Group Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Marex Group Limited earned a return on assets of 0.9% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is unchanged from the prior year. Earnings ranks banks on that return over three years, and Marex Group Limited scores 50/100 among other banks.
Marex Group Limited reported revenue of $2.0B in fiscal year 2025, against $1.6B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Marex Group Limited scores 84/100 among other banks.
Marex Group Limited funded 3.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $1.2B of equity against $34.7B of assets. Capital ranks banks on that cushion, and Marex Group Limited scores 2/100 among other banks.
Not available for Marex Group Limited, and counted as zero in the overall score.
Not available for Marex Group Limited, and counted as zero in the overall score.
Marex Group Limited reported net income of $307.7M in fiscal year 2025, against $218.0M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Marex Group Limited scores 36/100 among other banks.
Marex Group Limited passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Marex Group Limited generates $2.17 in operating cash flow ($667.5M OCF vs $307.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Marex Group Limited held $2.9B in cash against $87.4M in long-term debt as of Q4 2025, with $31.0B of liabilities due within a year.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
MRX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
MRX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2310-K | Q4'2210-K |
|---|---|---|---|---|
| Total Assets | $34.7B+42.6% | $24.3B+38.0% | $17.6B+11.9% | $15.7B |
| Current Assets | $33.7B+41.4% | $23.8B+40.7% | $16.9B+10.3% | $15.4B |
| Cash & Equivalents | $2.9B+12.7% | $2.6B+72.3% | $1.5B+63.0% | $910.1M |
| Accounts Receivable | $11.0B+45.5% | $7.6B+57.7% | $4.8B+2.2% | $4.7B |
| Goodwill | $237.4M+34.5% | $176.5M+7.9% | $163.6M+5.2% | $155.5M |
| Total Liabilities | $33.4B+43.2% | $23.3B+38.6% | $16.8B+11.7% | $15.1B |
| Current Liabilities | $31.0B+42.2% | $21.8B+37.1% | $15.9B+9.1% | $14.6B |
| Non-Current Liabilities | $2.4B+57.3% | $1.6B+63.7% | $951.0M+88.6% | $504.3M |
| Long-Term Debt | $87.4M+30.4% | $67.0M+70.1% | $39.4M+22.7% | $32.1M |
| Total Equity | $1.2B+19.4% | $976.9M+25.9% | $775.9M+14.5% | $677.7M |
| Retained Earnings | $982.0M+35.9% | $722.4M+30.1% | $555.3M+22.0% | $455.3M |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.
MRX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
MRX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Marex Group Limited MRX | FY2025 | $2.0B | $307.7M | 15.2% | $5.2B | 29/100 |
| CLEANSPARK INC CLSK | FY2026 | N/A | N/A | N/A | $2.7B | — |
| BGC Group, Inc. BGC | FY2025 | $2.9B | $155.0M | 5.3% | $5.4B | 49/100 |
| Hut 8 Corp. HUT | FY2025 | $235.1M | -$248.0M | N/A | $10.4B | 48/100 |
| StoneX Group Inc. SNEX | FY2025 | $131.0B | $305.9M | 0.2% | $7.4B | 53/100 |
| Virtu Financial, Inc. VIRT | FY2025 | $3.6B | $912K | 0.0% | $5.1B | 24/100 |
Where Marex Group Limited Ranks
Frequently Asked Questions
What is Marex Group Limited's annual revenue?
Marex Group Limited (MRX) reported $2.0B in total revenue for fiscal year 2025. This represents a 26.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Marex Group Limited's revenue growing?
Marex Group Limited (MRX) revenue grew by 26.9% year-over-year, from $1.6B to $2.0B in fiscal year 2025.
Is Marex Group Limited profitable?
Yes, Marex Group Limited (MRX) reported a net income of $307.7M in fiscal year 2025, with a net profit margin of 15.2%.
How much debt does Marex Group Limited have?
As of fiscal year 2025, Marex Group Limited (MRX) had $2.9B in cash and equivalents against $87.4M in long-term debt.
What is Marex Group Limited's net profit margin?
Marex Group Limited (MRX) had a net profit margin of 15.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Marex Group Limited's return on equity (ROE)?
Marex Group Limited (MRX) has a return on equity of 26.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Marex Group Limited's free cash flow?
Marex Group Limited (MRX) generated $654.4M in free cash flow during fiscal year 2025. This represents a -43.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Marex Group Limited's operating cash flow?
Marex Group Limited (MRX) generated $667.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Marex Group Limited's total assets?
Marex Group Limited (MRX) had $34.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Marex Group Limited's capital expenditures?
Marex Group Limited (MRX) invested $13.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Marex Group Limited's current ratio?
Marex Group Limited (MRX) had a current ratio of 1.09 as of fiscal year 2025, which is considered adequate.
What is Marex Group Limited's debt-to-equity ratio?
Marex Group Limited (MRX) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Marex Group Limited's return on assets (ROA)?
Marex Group Limited (MRX) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Marex Group Limited's P/E ratio?
Marex Group Limited (MRX) trades at 16.8x earnings, its market capitalization divided by net income of $307.7M net income, FY2025. The market capitalization is $5.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Marex Group Limited's price-to-sales ratio?
Marex Group Limited (MRX) trades at 2.6x sales, its market capitalization divided by revenue of $2.0B revenue, FY2025. The market capitalization is $5.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Marex Group Limited's Piotroski F-Score?
Marex Group Limited (MRX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Marex Group Limited's earnings high quality?
Marex Group Limited (MRX) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Marex Group Limited?
Marex Group Limited (MRX) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.